SPRC Latest Headlines

SciSparc’s NeuroThera Labs Clears Key Milestone in Phase IIb Tourette Trial for SCI-110

at www.tipranks.com (Fri, 23-Oct 7:27 AM)

SciSparc (SPRC) rallies as it outlines a shift toward Agentic AI in cybersecurity and finance

Market Chameleon (Thu, 15-Oct 10:24 AM)

SciSparc (SPRC) pivots toward agentic AI, targeting cybersecurity and finance applications

Market Chameleon (Thu, 15-Oct 8:01 AM)

SciSparc Spotlights Three Published U.S. Patent Applications Linking PEA With LSD, Ketamine, and Ibogaine

Market Chameleon (Thu, 24-Sep 11:45 AM)

SciSparc spotlights three published U.S. patent applications pairing PEA with LSD, ketamine, and ibogaine

Market Chameleon (Wed, 23-Sep 9:44 AM)

SciSparc’s Stake in NeuroThera Soars to C$30 Million After Financing: Majority Ownership Solidified

Market Chameleon (Tue, 18-Aug 8:34 AM)

SPRC Strengthens Patent Portfolio with Japanese Approval—Expanding Global Reach for Innovative Pain Therapies

Market Chameleon (Wed, 12-Aug 9:10 AM)

SciSparc's NeuroThera Launches Phase IIb Trial at Yale for Pioneering Tourette Syndrome Treatment

Market Chameleon (Wed, 5-Aug 9:00 AM)

SciSparc’s Quantum Platform Milestone Sets New Standard for Clinical Data Analytics

Market Chameleon (Fri, 31-Jul 9:18 AM)

SPRC Subsidiary NeuroThera Labs Validates Quantum Platform for Clinical Data on S&P 500 Infrastructure

Market Chameleon (Wed, 29-Jul 11:07 AM)

SciSparc’s NeuroThera Labs Validates Quantum Data Platform—A Leap Forward for Clinical Analytics

Market Chameleon (Wed, 29-Jul 9:08 AM)